3.91
1.76%
-0.07
After Hours:
3.91
Sight Sciences Inc stock is traded at $3.91, with a volume of 92,751.
It is down -1.76% in the last 24 hours and down -24.81% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$3.98
Open:
$3.97
24h Volume:
92,751
Relative Volume:
0.47
Market Cap:
$203.10M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-2.6781
EPS:
-1.46
Net Cash Flow:
$-47.98M
1W Performance:
+4.83%
1M Performance:
-24.81%
6M Performance:
-29.80%
1Y Performance:
+16.72%
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.91 | 203.10M | 81.06M | -55.55M | -47.98M | -1.46 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
Aug-21-24 | Initiated | Lake Street | Buy |
Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
Jan-06-23 | Upgrade | Stifel | Hold → Buy |
Oct-04-22 | Initiated | Needham | Hold |
Jul-26-22 | Initiated | Stifel | Hold |
Feb-03-22 | Initiated | William Blair | Outperform |
Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Millrace Asset Group Inc. Acquires New Shares in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat
GSA Capital Partners LLP Invests $136,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Independent Chairman Of Sight Sciences Sold 25% Of Their Shares - Simply Wall St
Hedge Fund and Insider Trading News: Ken Griffin, Bridgewater Associates, AQR Capital Management, Brookfield Asset Management, Sight Sciences Inc (SGHT), Royal Caribbean Cruises Ltd (RCL), and More - Insider Monkey
Sight sciences EVP Manohar Raheja acquires $7,400 in stock By Investing.com - Investing.com Nigeria
Sight sciences EVP Manohar Raheja acquires $7,400 in stock - Investing.com
Sight Sciences director Encrantz sells $2.06 million in stock - Investing.com India
SGHTSight Sciences, Inc. Latest Stock News & Market Updates - StockTitan
Top 3 Health Care Stocks You'll Regret Missing In November - MSN
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Sight Sciences to Present at Piper Sandler Healthcare Conference in December | SGHT Stock News - StockTitan
Sight Sciences, Inc. (NASDAQ:SGHT) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - Simply Wall St
Sight Sciences FY2024 EPS Estimate Raised by William Blair - MarketBeat
Sight Sciences Announces New Leadership Appointments - Vision Monday
Sight Sciences price target lowered to $5 from $7 at Morgan Stanley - Yahoo Finance
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates - MSN
Sight Sciences (NASDAQ:SGHT) Price Target Lowered to $5.00 at Morgan Stanley - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Q3 2024 Earnings Call Transcript - Insider Monkey
Sight Sciences Reports Third Quarter Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - Vision Monday
South Africa Dry Eye Treatment Devices Market Size & Outlook, 2030 - Grand View Research
Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Sight Sciences stock price target cut on Q3 revenue headwinds - Investing.com
Sight Sciences (NASDAQ:SGHT) Receives "Neutral" Rating from Piper Sandler - MarketBeat
Sight Sciences' (SGHT) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Sight Sciences stock price target cut on Q3 revenue headwinds By Investing.com - Investing.com UK
Sight Sciences Inc. (SGHT) PT Lowered to $5.50 at Piper Sandler - StreetInsider.com
Sight Sciences, Inc. (SGHT) Misses Q3 EPS by 1c - StreetInsider.com
Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Sight Sciences Reports Modest Growth and Optimistic Outlook - TipRanks
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations - The Manila Times
Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - The Manila Times
Sight Sciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Sight Sciences Appoints MK Raheja as Executive Vice - GlobeNewswire
Sight Sciences Strengthens Leadership: Ophthalmic Innovation Expert & Inogen Co-Founder Join Executive Team | SGHT Stock News - StockTitan
Sight Sciences Reports Revenue Growth and Leadership Change - TipRanks
Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Lake Street cuts Sight Sciences stock rating to hold amid market challenges - Investing.com Canada
Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold - StreetInsider.com
Sight Sciences (NASDAQ:SGHT) Rating Lowered to "Hold" at Lake Street Capital - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030 | DelveInsight - The Malaysian Reserve
Sight Sciences (SGHT) Scheduled to Post Earnings on Thursday - MarketBeat
Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for - MSN
Microsoft Co. (NASDAQ:MSFT) Shares Acquired by Parametrica Management Ltd - Defense World
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Preview: Zynex's Earnings - Benzinga
Sight Sciences CCO Matthew Link sells $244,900 in stock - Investing.com India
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in Stock - MarketBeat
Sight Sciences CCO Matthew Link sells $244,900 in stock By Investing.com - Investing.com South Africa
The Manufacturers Life Insurance Company Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):